Published in Mol Pharmacol on January 01, 1999
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci U S A (2003) 1.71
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell (2003) 1.60
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J (2006) 1.55
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A (2005) 1.49
Transferrin receptor-like proteins control the degradation of a yeast metal transporter. EMBO J (2006) 1.38
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem (2012) 1.34
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) (2005) 1.11
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination. Int J Cancer (2005) 1.07
Chemically synthesized molecules with the targeting and effector functions of antibodies. J Am Chem Soc (2014) 0.89
Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family. J Mol Evol (2006) 0.86
NAAG, NMDA receptor and psychosis. Curr Med Chem (2012) 0.83
Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II. Synapse (2009) 0.81
Structural characterization of Zn(II)-, Co(II)-, and Mn(II)-loaded forms of the argE-encoded N-acetyl-L-ornithine deacetylase from Escherichia coli. J Inorg Biochem (2012) 0.77
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Neurology and psychiatry: closing the great divide. Neurology (2000) 3.68
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
The glutamatergic basis of human alcoholism. Am J Psychiatry (1995) 3.20
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron (1989) 3.06
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol (1996) 2.56
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry (1998) 2.36
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol (1971) 2.08
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature (1976) 2.08
Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther (1969) 1.99
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J (1990) 1.86
Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science (1969) 1.81
Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol (1982) 1.79
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience (1991) 1.78
The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med (1998) 1.72
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A (1998) 1.71
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A (1996) 1.70
Pilot studies of telemedicine for patients with obsessive-compulsive disorder. Am J Psychiatry (1995) 1.66
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem (1987) 1.64
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Catecholamines in fetal and newborn rat brain. J Neurochem (1973) 1.55
Tyrosine hydroxylase in rat brain--cofactor requirements, regional and subcellular distribution. Biochem Pharmacol (1972) 1.49
N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol (1995) 1.47
Use of droperidol in hospitalized children. J Am Acad Child Adolesc Psychiatry (1998) 1.44
Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J Pharmacol Exp Ther (1969) 1.43
Hydroxychloroquine retinopathy. Ophthalmology (2001) 1.42
Goldenhar's syndrome. Arch Ophthalmol (1991) 1.40
Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Pediatrics (1991) 1.40
Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci (2008) 1.40
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci U S A (1979) 1.27
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. J Comp Neurol (1978) 1.25
Neurotoxic action of kainic acid. J Neurochem (1983) 1.24
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res (1979) 1.21
Keratoconus and eye rubbing. Am J Ophthalmol (1984) 1.20
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry (1998) 1.19
The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci (1992) 1.19
The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am J Psychiatry (1970) 1.18
Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells. J Biol Chem (1982) 1.17
Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol (1986) 1.15
Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature (1982) 1.15
Psychotropic drug use in very young children. JAMA (2000) 1.15
Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord (1991) 1.14
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry (1995) 1.13
Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet (1981) 1.13
Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci (1986) 1.13
Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J Neurochem (1991) 1.11
N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem (1984) 1.10
Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol (1983) 1.09
Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol (1992) 1.09
Selective destruction of neurons by a transmitter agonist. Science (1977) 1.08
Avoidance conditioning in different strains of rats: neurochemical correlates. Psychopharmacologia (1973) 1.08
Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J Neurochem (1991) 1.08
Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther (1989) 1.07
Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci (2000) 1.07
Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol (1999) 1.07
Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res (1976) 1.06
Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry (1980) 1.06
Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem (1998) 1.06
Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain. Brain Res (1976) 1.05
The neurobiologic consequences of Down syndrome. Brain Res Bull (1986) 1.04
Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol (1991) 1.04
Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res (1981) 1.04
Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci (1988) 1.04
Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J (1987) 1.04
The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study. J Comp Neurol (1978) 1.04
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature (1978) 1.03
Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation. Proc Natl Acad Sci U S A (1978) 1.03
N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor. Proc Natl Acad Sci U S A (1983) 1.03
Quantification of creatinine kinetic parameters in patients with acute renal failure. Kidney Int (1998) 1.02
Alzheimer's disease and Down's syndrome. Ann N Y Acad Sci (1982) 1.01
Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther (1998) 1.01
Neuronal localization of specific brain phosphoproteins. Brain Res (1978) 0.99
D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry (1996) 0.99
Heterogeneity of sodium-dependent excitatory amino acid uptake mechanisms in rat brain. J Neurosci Res (1986) 0.99
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry (1999) 0.98
Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry (1982) 0.98
Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study. J Neurochem (1976) 0.98
Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse (2000) 0.97
The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience (1995) 0.97
Striatal lesions with kainic acid: neurochemical characteristics. Brain Res (1977) 0.97
Cholinergic innervation of mouse forebrain structures. J Comp Neurol (1994) 0.97
N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. Proc Natl Acad Sci U S A (1985) 0.97
Implication of the JNK pathway in a rat model of Huntington's disease. Exp Neurol (2008) 0.96
Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. J Biol Chem (1990) 0.96
Serum haloperidol levels in Gilles de la Tourette syndrome. Biol Psychiatry (1981) 0.95
Development of the uptake and storage of L-( 3 H)norepinephrine in the rat brain. J Neurochem (1971) 0.95
Quisqualate-sensitive, chloride-dependent transport of glutamate into rat brain synaptosomes. J Neurosci Res (1987) 0.95
D-serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry (1999) 0.95